Heat Biologics Stock Revenue
Heat Biologics fundamentals help investors to digest information that contributes to Heat Biologics' financial success or failures. It also enables traders to predict the movement of Heat Stock. The fundamental analysis module provides a way to measure Heat Biologics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heat Biologics stock.
Heat |
Heat Revenue Analysis
Heat Biologics' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Heat Biologics Revenue | 2.11 M |
Most of Heat Biologics' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heat Biologics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Heat Biologics reported 2.11 M of revenue. This is 99.97% lower than that of the Healthcare sector and 99.72% lower than that of the Biotechnology industry. The revenue for all United States stocks is 99.98% higher than that of the company.
Heat Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heat Biologics' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heat Biologics could also be used in its relative valuation, which is a method of valuing Heat Biologics by comparing valuation metrics of similar companies.Heat Biologics is currently under evaluation in revenue category among related companies.
Heat Fundamentals
Return On Equity | -31.12 | |||
Return On Asset | -17.1 | |||
Current Valuation | (34.74 M) | |||
Shares Outstanding | 25.4 M | |||
Shares Owned By Insiders | 5.20 % | |||
Shares Owned By Institutions | 10.77 % | |||
Number Of Shares Shorted | 1.17 M | |||
Price To Earning | (1.29) X | |||
Price To Book | 0.48 X | |||
Price To Sales | 28.62 X | |||
Revenue | 2.11 M | |||
Gross Profit | (16.71 M) | |||
EBITDA | (32.93 M) | |||
Net Income | (35.07 M) | |||
Cash And Equivalents | 96.38 M | |||
Cash Per Share | 3.76 X | |||
Total Debt | 1.93 M | |||
Debt To Equity | 0.02 % | |||
Current Ratio | 21.04 X | |||
Book Value Per Share | 4.97 X | |||
Cash Flow From Operations | (38.13 M) | |||
Short Ratio | 4.43 X | |||
Earnings Per Share | (1.15) X | |||
Number Of Employees | 49 | |||
Beta | 0.3 | |||
Market Capitalization | 60.46 M | |||
Total Asset | 11.75 M | |||
Retained Earnings | (107.35 M) | |||
Working Capital | 6.77 M | |||
Current Asset | 11.27 M | |||
Current Liabilities | 4.5 M | |||
Z Score | -0.6 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Heat Biologics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Heat Biologics' short interest history, or implied volatility extrapolated from Heat Biologics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Heat Biologics information on this page should be used as a complementary analysis to other Heat Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Heat Stock
If you are still planning to invest in Heat Biologics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Heat Biologics' history and understand the potential risks before investing.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |